News
Oxford University Covid-19 vaccine raises hopes with strong trial results
Researchers at the University of Oxford believe they may have a breakthrough in their search for a Covid-19 vaccine after the team discovered that the jab could provide "double protection" against the deadly coronavirus following early stage human trials,...
News
Axil Integrated Services Retains Recipharm Contract
One of the biggest firms in the global pharmaceutical industry has asked Axil Integrated Services to continue delivering its total waste management solutions for the next three years.
Recipharm is one of the world’s top five pharmaceutical contract development and...
News
SkyCell assigned a critical supplier by EU Commission & Swiss Government
Vaccine supply chains must remain water-tight amid the oncoming sea of demand. With the flu season upon us and over 12.3 million confirmed cases of coronavirus, data solutions answer concerns around how to safely prepare for what’s ahead for...
News
Bionova Begins Construction of New Manufacturing Center
Bionova Scientific, a biologics CDMO with deep protein production, cell line development, process development and analytical expertise, has initiated construction of its new biologics manufacturing facility. Construction will be completed in approximately 10 months, with commissioning scheduled for Q3...
Clinical Trials
Moderna’s COVID-19 Vaccine Soon to Enter Phase 3 Trials as Phase 1 Shows Positive Results
Moderna, an American biotech company announced on July 14 that its COVID-19 vaccine candidate is finally going to enter the final phase on July 27 as it has shown positive results in previous human trials. Undoubtedly, this is a...
News
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
Roche and Blueprint Medicines Corporation announced the signing of a licensing and collaboration agreement providing exclusive rights to Roche for global co-development and commercialisation outside the USA, excluding Greater China*. In the US, Genentech, a member of the Roche...
News
Gilead presents additional data on investigational antiviral remdesivir to treat COVID-19 at Virtual COVID-19 Conference
Gilead Sciences Inc, announced additional data on remdesivir, an investigational antiviral for the treatment of COVID-19, adding to the available body of knowledge on treatment outcomes with remdesivir.
The data are being presented at the Virtual COVID-19 Conference as part...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
